U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975306) titled 'Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction' on April 21.
Brief Summary: All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Befo...